(Q37750546)

22 August 2017

1 reference

title

Nonalcoholic fatty liver disease and the coronary artery disease (English)

1 reference

metabolic dysfunction–associated steatotic liver disease

22 August 2017

0 references

1 reference

1 reference

inferred from title

author name string

Sombat Treeprasertsuk

series ordinal

1

1 reference

22 August 2017

Francisco Lopez-Jimenez

series ordinal

2

1 reference

22 August 2017

Keith D Lindor

series ordinal

3

1 reference

22 August 2017

publication date

13 May 2010

1 reference

Digestive Diseases and Sciences

22 August 2017

published in

1 reference

22 August 2017

volume

56

1 reference

22 August 2017

issue

1

1 reference

22 August 2017

page(s)

35-45

1 reference

https://scigraph.springernature.com/pub.10.1007/s10620-010-1241-2

22 August 2017

exact match

0 references

cites work

Metabolic syndrome may not be a good predictor of coronary artery disease in the Iranian population: population-specific definitions are required.

1 reference

https://api.crossref.org/works/10.1007%2FS10620-010-1241-2

Nonalcoholic fatty liver disease is a novel predictor of cardiovascular disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-010-1241-2

Prediction of Coronary Heart Disease Using Risk Factor Categories

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-010-1241-2

C-reactive protein, insulin resistance, central obesity, and coronary heart disease risk in Indian Asians from the United Kingdom compared with European whites.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-010-1241-2

Cardiovascular disease under the influence of excess visceral fat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-010-1241-2

Effects of comprehensive lifestyle modification on diet, weight, physical fitness, and blood pressure control: 18-month results of a randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-010-1241-2

Randomized controlled trial testing the effects of weight loss on nonalcoholic steatohepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-010-1241-2

Hypoadiponectinemia is associated with impaired glucose tolerance and coronary artery disease in non-diabetic men.

21 January 2018

1 reference

12 December 2020

Alanine aminotransferase predicts coronary heart disease events: A 10-year follow-up of the Hoorn Study

1 reference

12 December 2020

Losartan reduces liver expression of plasminogen activator inhibitor-1 (PAI-1) in a high fat-induced rat nonalcoholic fatty liver disease model

1 reference

12 December 2020

Screening and treating adults for lipid disorders.

1 reference

12 December 2020

Nonalcoholic fatty liver disease: a manifestation of the metabolic syndrome.

1 reference

12 December 2020

The severity of nonalcoholic fatty liver disease is associated with increased cardiovascular risk in a large cohort of non-obese Asian subjects

1 reference

12 December 2020

High sensitivity C-reactive protein values do not reliably predict the severity of histological changes in NAFLD.

1 reference

12 December 2020

Patients with elevated liver enzymes are not at higher risk for statin hepatotoxicity

1 reference

12 December 2020

Pioglitazone versus vitamin E versus placebo for the treatment of non-diabetic patients with non-alcoholic steatohepatitis: PIVENS trial design

1 reference

12 December 2020

Effect of bariatric surgery on nonalcoholic fatty liver disease: systematic review and meta-analysis

1 reference

12 December 2020

Nonalcoholic steatohepatitis: An expanded clinical entity

1 reference

12 December 2020

Relationship between interleukin 6 and mortality in patients with unstable coronary artery disease: effects of an early invasive or noninvasive strategy

1 reference

12 December 2020

Physical inactivity, abdominal obesity and risk of coronary heart disease in apparently healthy men and women

1 reference

12 December 2020

Nonalcoholic fatty liver disease

1 reference

12 December 2020

The distribution of 10-Year risk for coronary heart disease among US adults: findings from the National Health and Nutrition Examination Survey III.

1 reference

12 December 2020

Orlistat for overweight subjects with nonalcoholic steatohepatitis: A randomized, prospective trial

1 reference

12 December 2020

Clinical and pathologic risk factors for atherosclerosis in cirrhosis: a comparison between NASH-related cirrhosis and cirrhosis due to other aetiologies

1 reference

12 December 2020

Therapeutic effect of ARBs on insulin resistance and liver injury in patients with NAFLD and chronic hepatitis C: a pilot study

1 reference

12 December 2020

Cholesterol lowering with statin drugs, risk of stroke, and total mortality. An overview of randomized trials

1 reference

12 December 2020

Central obesity: association with left ventricular dysfunction and mortality in the community

1 reference

12 December 2020

The many roles of chemokines and chemokine receptors in inflammation

1 reference

12 December 2020

Epidemiology of non-alcoholic fatty liver disease in China.

1 reference

12 December 2020

Waist circumference as a screening tool for cardiovascular risk factors: evaluation of receiver operating characteristics (ROC)

1 reference

12 December 2020

Pathology of nonalcoholic steatohepatitis

1 reference

12 December 2020

Physical activity during leisure time and primary prevention of coronary heart disease: an updated meta-analysis of cohort studies

1 reference

12 December 2020

Effect of a lifestyle intervention in patients with abnormal liver enzymes and metabolic risk factors

1 reference

12 December 2020

Association between nonalcoholic fatty liver disease and coronary artery disease

1 reference

12 December 2020

Adiponectin and cardiovascular risk prediction: can the ambiguities be resolved?

1 reference

12 December 2020

Chemokines in the pathogenesis of vascular disease

1 reference

12 December 2020

Pathogenesis of non-alcoholic steatohepatitis: human data

1 reference

12 December 2020

Design and validation of a histological scoring system for nonalcoholic fatty liver disease

1 reference

12 December 2020

NASH predicts plasma inflammatory biomarkers independently of visceral fat in men

1 reference

12 December 2020

NAFLD, obesity, and bariatric surgery

1 reference

12 December 2020

Endothelial dysfunction and cardiovascular risk profile in nonalcoholic fatty liver disease.

1 reference

12 December 2020

Angiotensin receptor blockers in the treatment of NASH/NAFLD: could they be a first-class option?

1 reference

12 December 2020

Hepatic, cardiovascular, and endocrine outcomes of the histological subphenotypes of nonalcoholic fatty liver disease.

1 reference

12 December 2020

Effects of combination lipid therapy on coronary stenosis progression and clinical cardiovascular events in coronary disease patients with metabolic syndrome: a combined analysis of the Familial Atherosclerosis Treatment Study (FATS), the HDL-Athero

1 reference

12 December 2020

Association among C-reactive protein, Fatty liver disease, and cardiovascular risk

1 reference

12 December 2020

Randomized, placebo-controlled trial of pioglitazone in nondiabetic subjects with nonalcoholic steatohepatitis

1 reference

12 December 2020

The metabolic syndrome--a new worldwide definition

1 reference

12 December 2020

High-sensitivity C-reactive protein is an independent clinical feature of nonalcoholic steatohepatitis (NASH) and also of the severity of fibrosis in NASH.

1 reference

12 December 2020

Nonalcoholic fatty liver disease as a component of the metabolic syndrome

1 reference

12 December 2020

Mice heterozygous for a defect in mitochondrial trifunctional protein develop hepatic steatosis and insulin resistance

1 reference

12 December 2020

Association between nonalcoholic fatty liver disease and coronary artery calcification

1 reference

12 December 2020

Bariatric surgery and reduction in morbidity and mortality: experiences from the SOS study

1 reference

12 December 2020

Chemokines--chemotactic cytokines that mediate inflammation

1 reference

12 December 2020

Clinical implications of elevated serum interleukin-6, soluble CD40 ligand, metalloproteinase-9, and tissue inhibitor of metalloproteinase-1 in patients with acute ST-segment elevation myocardial infarction.

1 reference

12 December 2020

Statins and hepatotoxicity: focus on patients with fatty liver

1 reference

12 December 2020

Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III)

1 reference

12 December 2020

Increased liver fat, impaired insulin clearance, and hepatic and adipose tissue insulin resistance in type 2 diabetes

1 reference

12 December 2020

Efficacy and safety of high-dose pravastatin in hypercholesterolemic patients with well-compensated chronic liver disease: Results of a prospective, randomized, double-blind, placebo-controlled, multicenter trial

1 reference

12 December 2020

Markers of inflammation and cardiovascular disease: application to clinical and public health practice: A statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association

1 reference

12 December 2020

Long-term follow-up of patients with NAFLD and elevated liver enzymes

1 reference

12 December 2020

Nonalcoholic fatty liver disease: a spectrum of clinical and pathological severity

1 reference

12 December 2020

Long-term follow-up of patients with nonalcoholic fatty liver

1 reference

12 December 2020

Insulin sensitizers in nonalcoholic fatty liver disease and steatohepatitis: Current status

1 reference

12 December 2020

Low grade inflammation and coronary heart disease: prospective study and updated meta-analyses

1 reference

12 December 2020

Effects of therapeutic lifestyle program on ultrasound-diagnosed nonalcoholic fatty liver disease

1 reference

12 December 2020

Increased hepatic myeloperoxidase activity in obese subjects with nonalcoholic steatohepatitis

1 reference

12 December 2020

The natural history of nonalcoholic fatty liver disease: a population-based cohort study

1 reference

12 December 2020

Insulin resistance and endothelial dysfunction: the road map to cardiovascular diseases

1 reference

12 December 2020

1 reference

12 December 2020

High cardiorespiratory fitness is an independent predictor of the reduction in liver fat during a lifestyle intervention in non-alcoholic fatty liver disease

1 reference

12 December 2020

Fatty liver is associated with insulin resistance, risk of coronary heart disease, and early atherosclerosis in a large European population

1 reference

12 December 2020

Association between myeloperoxidase levels and risk of coronary artery disease

1 reference

12 December 2020

Blood pressure and fasting plasma glucose rather than metabolic syndrome predict coronary artery calcium progression: the Rancho Bernardo Study

1 reference

12 December 2020

The effects of discontinuing pioglitazone in patients with nonalcoholic steatohepatitis

1 reference

12 December 2020

Effectiveness of antiplatelet drugs against experimental non-alcoholic fatty liver disease

1 reference

12 December 2020

Nonalcoholic fatty liver disease: from steatosis to cirrhosis

1 reference

12 December 2020

Elevated serum alanine aminotransferase activity and calculated risk of coronary heart disease in the United States.

1 reference

12 December 2020

[Assessment of cardiovascular risk in population groups. Comparison of Score system and Framingham in hypertensive patients].

1 reference

12 December 2020

Relation of inflammatory chemokines to insulin resistance and hypoadiponectinemia in coronary artery disease patients

1 reference

12 December 2020

Metabolic syndrome and Framingham risk score for prediction of cardiovascular events in Caribbean Indian patients with blood glucose abnormalities

1 reference

12 December 2020

Relations between carotid artery wall thickness and liver histology in subjects with nonalcoholic fatty liver disease

1 reference

12 December 2020

Association of hypoadiponectinemia in men with early onset of coronary heart disease and multiple coronary artery stenoses

1 reference

12 December 2020

Pioglitazone and risk of cardiovascular events in patients with type 2 diabetes mellitus: a meta-analysis of randomized trials

1 reference

12 December 2020

Adjustable gastric banding and conventional therapy for type 2 diabetes: a randomized controlled trial

1 reference

12 December 2020

Cholesterol reduction yields clinical benefit: impact of statin trials

1 reference

12 December 2020

Behavior therapy for nonalcoholic fatty liver disease: The need for a multidisciplinary approach

1 reference

12 December 2020

Drugs improving insulin resistance for non-alcoholic fatty liver disease and/or non-alcoholic steatohepatitis

1 reference

12 December 2020

Effects of Bariatric Surgery on Mortality in Swedish Obese Subjects

1 reference

12 December 2020

Pravastatin in patients with nonalcoholic steatohepatitis: results of a pilot study

1 reference

12 December 2020

Final results of a long-term, clinical follow-up in fatty liver patients

1 reference

12 December 2020

Effect of Rosiglitazone on the Risk of Myocardial Infarction and Death from Cardiovascular Causes

1 reference

12 December 2020

Hepatic steatosis and subclinical cardiovascular disease in a cohort enriched for type 2 diabetes: the Diabetes Heart Study

1 reference

12 December 2020

Non-alcoholic fatty liver disease and insulin resistance.

1 reference

12 December 2020

Laparoscopic adjustable gastric banding for the treatment of morbid (grade 3) obesity and its metabolic complications: a three-year study.

1 reference

12 December 2020

Long-term mortality after gastric bypass surgery

1 reference

12 December 2020

One-year intense nutritional counseling results in histological improvement in patients with non-alcoholic steatohepatitis: a pilot study

1 reference

12 December 2020

Prevalence of nonalcoholic fatty liver disease and its association with cardiovascular disease among type 2 diabetic patients

1 reference

12 December 2020

Prognostic value of myeloperoxidase in patients with chest pain

1 reference

12 December 2020

Long term prognosis of fatty liver: risk of chronic liver disease and death.

1 reference

12 December 2020

Clinical trial: pilot study of metformin for the treatment of non-alcoholic steatohepatitis.

1 reference

12 December 2020

Visceral fat: a key mediator of steatohepatitis in metabolic liver disease.

1 reference

12 December 2020

Increased overall mortality and liver-related mortality in non-alcoholic fatty liver disease.

1 reference

12 December 2020

10.1007/S10620-010-1241-2

Identifiers

DOI

1 reference

22 August 2017

1 reference